CLINICAL IMPRESSION: PLANNED PERCUTANEOUS CORONARY INTERVENTION IN A PATIENT WITH ATRIAL FIBRILLATION

CLINICAL IMPRESSION: PLANNED PERCUTANEOUS CORONARY INTERVENTION IN A PATIENT WITH ATRIAL FIBRILLATION

The paper presents the clinical discussion of a patient with atrial fibrillation, who underwent a planned percutaneous coronary intervention. It also provides the recommendations for modern principles in diagnosis, the choice of optimal antithrombotic therapy in this pathology.

Bibliographic Details
Main Author:	Andrei I. Komarov
Format:	Article
Language:	Russian
Published:	«REMEDIUM GROUP» Ltd. 2018-12-01
Series:	Атеротромбоз
Subjects:	percutaneous coronary intervention atrial fibrillation multicomponent antithrombotic therapy
Online Access:	https://www.aterotromboz.ru/jour/article/view/170

Similar Items

COMBINED ANTITHROMBOTIC THERAPY IN CASE OF PLANNED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ATRIAL FIBRILLATION IN ACTUAL CLINICAL PRACTICE
by: N. Yu. Khorkova, et al.
Published: (2018-12-01)

Antithrombotic management in atrial fibrillation patients following percutaneous coronary intervention: A clinical review
by: Yuichi Saito, et al.
Published: (2024-10-01)

Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020?
by: E. P. Panchenko
Published: (2020-12-01)

STRATEGY TO MINIMIZE THE BLEEDING RISKS IN PATIENTS WITH ATRIAL FIBRILLATION WHO RECEIVE COMBINED ANTITHROMBOTIC THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
by: D. A. Zateishchikov
Published: (2018-05-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Modern strategy of antithrombotic therapy in patients with coronary artery disease and atrial fibrillation after percutaneous coronary intervention
by: Yu. A. Karpov
Published: (2019-12-01)

THE SPECIFICS OF PRESCRIBING TRIPLE ANTITROMBOTIC THERAPY WITH RIVAROXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CORONARY ARTERY STENTING
by: N. A. Novikova, et al.
Published: (2017-05-01)

Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
by: Yunan Yu, et al.
Published: (2022-10-01)

Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention
by: E. N. Krivosheeva, et al.
Published: (2021-08-01)

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis
by: Mitsuru Ishii, et al.
Published: (2022-11-01)

NEW PROSPECTS OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATIO AND CORONARY ARTERY STENTS: DABIGATRAN POTENTIAL
by: M. Yu. GILYAROV, et al.
Published: (2017-12-01)

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
by: Monika Kozieł, et al.
Published: (2020-03-01)

ASPECTS OF MULTICOMPONENT THERAPY AND PERIOPERATIVE TACTICS IN A PATIENT WITH ATRIAL FIBRILLATION RECEIVING RIVAROXABAN THERAPY. CLINICAL OBSERVATION
by: O. A. Zemlyanskaya, et al.
Published: (2019-06-01)

Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention
by: Mattia Galli, et al.
Published: (2022-08-01)

HOW TO MINIMIZE THE BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS: LESSONS DRAWN FROM RANDOMIZED TRIALS AND NEW CLINICAL GUIDELINES
by: O. O. Shakhmatova, et al.
Published: (2018-05-01)

Advances of safety of antithrombotic therapy in patients with chronic kidney disease plus atrial fibrillation after percutaneous coronary intervention
by: Jia-xuan Ning, et al.
Published: (2024-09-01)

Is triple antithrombotic therapy a safe option in patients with AF who receive drug-eluting stents?: a review article
by: Ali Alshahrani, et al.
Published: (2023-08-01)

Atrial Fibrillation and Chronic Coronary Ischemia: A Challenging Vicious Circle
by: Alexandru Florinel Oancea, et al.
Published: (2023-06-01)

Antithrombotic strategy in cancer patients comorbid with acute coronary syndrome and atrial fibrillation
by: Tianbo Wang, et al.
Published: (2023-12-01)

Bleeding risk factors and real-world antithrombotic therapies in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention: a retrospective study
by: Kanako Fujita, et al.
Published: (2023-12-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study
by: Yimeng Wang, et al.
Published: (2024-07-01)

Thrombosis prevention in percutaneous coronary interventions
by: V. P. Lupanov, et al.
Published: (2009-08-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

Predictive performance of different bleeding risk scores in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention
by: Si-Qi Lyu, et al.
Published: (2022-08-01)

A network meta-analysis of the antithrombotic strategies in patients with atrial fibrillation and percutaneous coronary interventions: Focus on bleeding
by: Kyriakos Dimitriadis, et al.
Published: (2023-09-01)

Topical issues of dabigatran use in combination antithrombotic therapy in patients with acute coronary syndrome and nonvalvular atrial fibrillation
by: N. A. Novikova, et al.
Published: (2020-06-01)

D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention
by: Diona Gjermeni, et al.
Published: (2024-05-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Sulimov, et al.
Published: (2016-01-01)

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)
by: O. V. Reshetko, et al.
Published: (2020-11-01)

NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES
by: G. S. Galjautdinov1, et al.
Published: (2018-07-01)

Percutaneous coronary intervention-lobectomy for Lung Cancer hybrid surgery: an initial case series
by: Jing Zeng, et al.
Published: (2025-02-01)

The quality of prior antithrombotic therapy and the severity of ischemic stroke in atrial fibrillation
by: L. A. Geraskina, et al.
Published: (2020-10-01)

Percutaneous Coronary Interventions Using a Ridaforolimus‐Eluting Stent in Patients at High Bleeding Risk
by: Ran Kornowski, et al.
Published: (2024-01-01)

Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial
by: Marat Fudim, et al.
Published: (2021-12-01)

Real-world antithrombotic strategies in patients with atrial fibrillation and recently developed acute coronary syndrome
by: Hiroshi Iwata, et al.
Published: (2025-03-01)

Secondary prevention therapies following percutaneous coronary intervention or acute coronary syndrome in patients with diabetes mellitus
by: Arnaud Planchat, et al.
Published: (2024-11-01)

Efficiency of prognostic scores in predicting the new-onset atrial fibrillation in patients with ST-elevation myocardial infarction after percutaneous coronary intervention
by: R. L. Pak, et al.
Published: (2025-01-01)

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016-01-01)

A case report of ventricular fibrillation following Shockwave intravascular lithotripsy during percutaneous coronary intervention
by: Lars Jakobsen, et al.
Published: (2024-04-01)